Please use this identifier to cite or link to this item: http://hdl.handle.net/11054/2103
Full metadata record
DC FieldValueLanguage
dc.contributorSayner, Aleshaen_US
dc.contributorRogers, F.en_US
dc.contributorTran, J.en_US
dc.contributorJovanovic, E.en_US
dc.contributorHenningham, L.en_US
dc.contributorNahon, I.en_US
dc.date.accessioned2023-02-20T04:43:35Z-
dc.date.available2023-02-20T04:43:35Z-
dc.date.issued2022-
dc.identifier.govdoc02075en_US
dc.identifier.urihttp://hdl.handle.net/11054/2103-
dc.description.abstractObjective Overactive bladder (OAB) is a condition that has physical, social, psychosocial, and financial impacts. Transcutaneous tibial nerve stimulation (TTNS) is a modality that stimulates the nerve root fibers of L5-S3, the same spinal segments of the parasympathetic nervous system as the bladder. This scoping review aims to identify current literature available on the feasibility and outcomes of TTNS as a first-line treatment option for OAB. Materials and Methods A scoping review of six electronic data bases was performed to identify full-text articles from 2015 that explored the impact of TTNS on OAB and bladder dysfunction in people aged >18 years. Results A total of 15 articles met the inclusion criteria. TTNS was compared with sham treatment, parasacral stimulation, pelvic floor muscle training (PFMT), anticholinergic medication, and percutaneous tibial nerve stimulation (PTNS). Heterogeneity in treatment application and parameters existed, with variations in treatment duration, frequency of use, and treatment settings such as pulse width (μs) and frequency (Hz). Results indicated that TTNS has efficacy equal to PFMT and PTNS in the management of OAB; however, it is not as efficacious as anticholinergic medication. Conclusions TTNS is a promising first-line management option for people with OAB, particularly in the older population and for those with neurogenic bladder. It can provide symptomatic relief from urinary incontinence, frequency, urgency, and nocturia, while avoiding the bothersome side effects of more invasive or pharmaceutical therapies. Heterogeneity in treatment parameters limits generalizability and translation of the most appropriate clinical application and should be considered in future trials.en_US
dc.description.provenanceSubmitted by Gemma Siemensma (gemmas@bhs.org.au) on 2023-02-10T04:51:04Z No. of bitstreams: 0en
dc.description.provenanceApproved for entry into archive by Gemma Siemensma (gemmas@bhs.org.au) on 2023-02-20T04:43:35Z (GMT) No. of bitstreams: 0en
dc.description.provenanceMade available in DSpace on 2023-02-20T04:43:35Z (GMT). No. of bitstreams: 0 Previous issue date: 2022en
dc.titleTranscutaneous tibial nerve stimulation in the management of overactive bladder: A scoping review.en_US
dc.typeJournal Articleen_US
dc.type.specifiedArticleen_US
dc.bibliographicCitation.titleNeuromodulationen_US
dc.bibliographicCitation.volume25en_US
dc.bibliographicCitation.issue8en_US
dc.bibliographicCitation.stpage1086en_US
dc.bibliographicCitation.endpage1096en_US
dc.subject.healththesaurusEFFECTIVENESSen_US
dc.subject.healththesaurusOVERACTIVE BLADDERen_US
dc.subject.healththesaurusPHYSIOTHERAPYen_US
dc.subject.healththesaurusSCOPING REVIEWen_US
dc.subject.healththesaurusTRANSCUTANEOUS TIBIAL NERVE STIMULATIONen_US
dc.identifier.doihttps://doi.org/10.1016/j.neurom.2022.04.034en_US
Appears in Collections:Research Output

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.